Analysis of early hypertension (HTN) and clinical outcome with bevacizumab (BV).
暂无分享,去创建一个
G. Sledge | P. Douglas | H. Hurwitz | O. Rosen | D. Reardon | J. Middleton | D. Chen | David H. Johnson | D. Chen
暂无分享,去创建一个
G. Sledge | P. Douglas | H. Hurwitz | O. Rosen | D. Reardon | J. Middleton | D. Chen | David H. Johnson | D. Chen